Small molecule regulation of protein conformation by binding in the flap of HIV protease

ACS Chemical Biology

Volumn 8, Issue 6, 2013, Pages 1223-1231

  Tiefenbrunn, Theresa ^a   Forli, Stefano ^a   Baksh, Michael M ^a   Chang, Max W ^a   Happer, Meaghan ^a   Lin, Ying Chuan ^a   Perryman, Alexander L ^a   Rhee, Jin Kyu ^a   Torbett, Bruce E ^a   Olson, Arthur J ^a   Elder, John H ^a   Finn, M G ^a   Stout, C David ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN; BENZOTRIPT; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE; INDOLE 6 CARBOXYLIC ACID; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; ENZYME BINDING; ENZYME REGULATION; FLUOROMETRY; HUMAN IMMUNODEFICIENCY VIRUS; INTERFEROMETRY; NONHUMAN; PRIORITY JOURNAL;

CRYSTALLOGRAPHY, X-RAY; HIV INFECTIONS; HIV PROTEASE; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; INDOLES; MOLECULAR DOCKING SIMULATION; PEPSTATINS; PROPIONATES; PROTEIN CONFORMATION;

EID: 84879761645     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb300611p     Document Type: Article

References (48)

1. Wheeler, W. H., Ziebell, R. A., Zabina, H., Pieniazek, D., Prejean, J., Bodnar, U. R., Mahle, K. C., Heneine, W., Johnson, J. A., and Hall, H. I. (2010) Prevalence of transmitted drug resistance associated mutations and HIV-1 subtypes in new HIV-1 diagnoses, U.S.-2006 AIDS 24, 1203-1212
2. UNAIDS. (2010) UNAIDS report on the global AIDS epidemic 2010, Joint United Nations Programme on HIV/AIDS (UNAIDS), Geneva, Switzerland.
3. Shen, L. and Siliciano, R. F. (2008) Viral reservoirs, residual viremia, and the potential of highly active antiretroviral therapy to eradicate HIV infection J. Allergy. Clin. Immunol. 122, 22-28
4. Ali, A., Bandaranayake, R. M., Cai, Y., King, N. M., Kolli, M., Mittal, S., Murzycki, J. F., Nalam, M. N., Nalivaika, E. A., Ozen, A., Prabu-Jeyabalan, M. M., Thayer, K., and Schiffer, C. A. (2011) Molecular basis for drug resistance in HIV-1 protease Viruses 2, 2509-2535
5. Wensing, A. M., van Maarseveen, N. M., and Nijhuis, M. (2009) Fifteen years of HIV protease inhibitors: raising the barrier to resistance Antiviral Res. 85, 59-74
6. De Clercq, E. (1999) Perspectives of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection Farmaco 54, 26-45
7. Lee, G. M. and Craik, C. S. (2009) Trapping moving targets with small molecules Science 324, 213-215
8. Kovalevsky, A. Y., Liu, F., Leshchenko, S., Ghosh, A. K., Louis, J. M., Harrison, R. W., and Weber, I. T. (2006) Ultra-high resolution crystal structure of HIV-1 protease mutant reveals two binding sites for clinical inhibitor TMC114 J. Mol. Biol. 363, 161-173
9. Kovalevsky, A. Y., Ghosh, A. K., and Weber, I. T. (2008) Solution kinetics measurements suggest HIV-1 protease has two binding sites for darunavir and amprenavir J. Med. Chem. 51, 6599-6603
10. Kovalevsky, A. Y., Louis, J. M., Aniana, A., Ghosh, A. K., and Weber, I. T. (2008) Structural evidence for effectiveness of darunavir and two related antiviral inhibitors against HIV-2 protease J. Mol. Biol. 384, 178-192
11. Prabu-Jeyabalan, M., Nalivaika, E., and Schiffer, C. A. (2002) Substrate shape determines specificity of recognition for HIV-1 protease: analysis of crystal structures of six substrate complexes Structure 10, 369-381
12. Nalam, M. N., Ali, A., Altman, M. D., Reddy, G. S., Chellappan, S., Kairys, V., Ozen, A., Cao, H., Gilson, M. K., Tidor, B., Rana, T. M., and Schiffer, C. A. (2010) Evaluating the substrate-envelope hypothesis: structural analysis of novel HIV-1 protease inhibitors designed to be robust against drug resistance J. Virol. 84, 5368-5378
13. Perryman, A. L., Lin, J. H., and McCammon, J. A. (2004) HIV-1 protease molecular dynamics of a wild-type and of the V82F/I84V mutant: Possible contributions to drug resistance and a potential new target site for drugs Protein Sci. 13, 1108-1123
14. Azam, M., Powers, J. T., Einhorn, W., Huang, W. S., Shakespeare, W. C., Zhu, X., Dalgarno, D., Clackson, T., Sawyer, T. K., and Daley, G. Q. (2010) AP24163 inhibits the gatekeeper mutant of BCR-ABL and suppresses in vitro resistance Chem. Biol. Drug Des. 75, 223-227
15. Zhang, J., Adrian, F. J., Jahnke, W., Cowan-Jacob, S. W., Li, A. G., Iacob, R. E., Sim, T., Powers, J., Dierks, C., Sun, F., Guo, G. R., Ding, Q., Okram, B., Choi, Y., Wojciechowski, A., Deng, X., Liu, G., Fendrich, G., Strauss, A., Vajpai, N., Grzesiek, S., Tuntland, T., Liu, Y., Bursulaya, B., Azam, M., Manley, P. W., Engen, J. R., Daley, G. Q., Warmuth, M., and Gray, N. S. (2010) Targeting Bcr-Abl by combining allosteric with ATP-binding-site inhibitors Nature 463, 501-506
16. Perryman, A. L., Zhang, Q., Soutter, H. H., Rosenfeld, R., McRee, D. E., Olson, A. J., Elder, J. E., and Stout, C. D. (2010) Fragment-based screen against HIV protease Chem. Biol. Drug Des. 75, 257-268
17. Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., and Olson, A. J. (2009) AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility J. Comput. Chem. 30, 2785-2791
18. Heaslet, H., Rosenfeld, R., Giffin, M., Lin, Y.-C., Tam, K., Torbett, B. E., Elder, J. H., McRee, D. E., and Stout, C. D. (2007) Conformational flexibility in the flap domains of ligand-free HIV protease Acta Crystallogr., Sect. D: Biol. Crystallogr. 63, 866-875
19. Fitzgerald, P. M., McKeever, B. M., VanMiddlesworth, J. F., Springer, J. P., Heimbach, J. C., Leu, C. T., Herber, W. K., Dixon, R. A., and Darke, P. L. (1990) Crystallographic analysis of a complex between human immunodeficiency virus type 1 protease and acetyl-pepstatin at 2.0-A resolution J. Biol. Chem. 265, 14209-14219
20. Mildner, A. M., Rothrock, D. J., Leone, J. W., Bannow, C. A., Lull, J. M., Reardon, I. M., Sarcich, J. L., Howe, W. J., Tomich, C. S., and Smith, C. W. 1994, The HIV-1 protease as enzyme and substrate: mutagenesis of autolysis sites and generation of a stable mutant with retained kinetic properties Biochemistry 33, 9405-9413
21. Scott, W. R. and Schiffer, C. A. (2000) Curling of flap tips in HIV-1 protease as a mechanism for substrate entry and tolerance of drug resistance Structure 8, 1259-1265
22. Katoh, E., Louis, J. M., Yamazaki, T., Gronenborn, A. M., Torchia, D. A., and Ishima, R. (2003) A solution NMR study of the binding kinetics and the internal dynamics of an HIV-1 protease-substrate complex Protein Sci. 12, 1376-1385
23. Freedberg, D. I., Ishima, R., Jacob, J., Wang, Y. X., Kustanovich, I., Louis, J. M., and Torchia, D. A. (2002) Rapid structural fluctuations of the free HIV protease flaps in solution: Relationship to crystal structures and comparison with predictions of dynamics calculations Protein Sci. 11, 221-232
24. Ishima, R., Freedberg, D. I., Wang, Y. X., Louis, J. M., and Torchia, D. A. (1999) Flap opening and dimer-interface flexibility in the free and inhibitor-bound HIV protease, and their implications for function Struct. Folding Des. 7, 1047-1055
25. Galiano, L., Bonora, M., and Fanucci, G. E. (2007) Interflap distances in HIV-1 protease determined by pulsed EPR measurements J. Am. Chem. Soc. 129, 11004-11005
26. Ding, F., Layten, M., and Simmerling, C. (2008) Solution structure of HIV-1 protease flaps probed by comparison of molecular dynamics simulation ensembles and EPR experiments J. Am. Chem. Soc. 130, 7184-7185
27. Kear, J. L., Blackburn, M. E., Veloro, A. M., Dunn, B. M., and Fanucci, G. E. (2009) Subtype polymorphisms among HIV-1 protease variants confer altered flap conformations and flexibility J. Am. Chem. Soc. 131, 14650-14651
28. Blackburn, M. E., Veloro, A. M., and Fanucci, G. E. (2009) Monitoring inhibitor-induced conformational population shifts in HIV-1 protease by pulsed EPR spectroscopy Biochemistry 48, 8765-8767
29. Torbeev, V. Y., Raghuraman, H., Hamelberg, D., Tonelli, M., Westler, W. M., Perozo, E., and Kent, S. B. (2011) Protein conformational dynamics in the mechanism of HIV-1 protease catalysis Proc. Natl. Acad. Sci. U.S.A. 108, 20982-20987
30. Torbeev, V. Y., Raghuraman, H., Mandal, K., Senapati, S., Perozo, E., and Kent, S. B. (2009) Dynamics of ″flap″ structures in three HIV-1 protease/inhibitor complexes probed by total chemical synthesis and pulse-EPR spectroscopy J. Am. Chem. Soc. 131, 884-885
31. Pillai, B., Kannan, K. K., and Hosur, M. V. (2001) 1.9 A X-ray study shows closed flap conformation in crystals of tethered HIV-1 PR Proteins 43, 57-64
32. Das, A., Mahale, S., Prashar, V., Bihani, S., Ferrer, J. L., and Hosur, M. V. (2010) X-ray snapshot of HIV-1 protease in action: observation of tetrahedral intermediate and short ionic hydrogen bond SIHB with catalytic aspartate J. Am. Chem. Soc. 132, 6366-6373
33. Kumar, M., Kannan, K. K., Hosur, M. V., Bhavesh, N. S., Chatterjee, A., Mittal, R., and Hosur, R. V. (2002) Effects of remote mutation on the autolysis of HIV-1 PR: X-ray and NMR investigations Biochem. Biophys. Res. Commun. 294, 395-401
34. Mittal, S., Cai, Y., Nalam, M. N. L., Bolon, D. N. A., and Schiffer, C. A. (2012) Hydrophobic core flexibility modulates enzyme activity in HIV-1 protease J. Am. Chem. Soc. 134, 4163-4168
35. Bihani, S. C., Das, A., Prashar, V., Ferrer, J. L., and Hosur, M. V. (2009) Resistance mechanism revealed by crystal structures of unliganded nelfinavir-resistant HIV-1 protease non-active site mutants N88D and N88S Biochem. Biophys. Res. Commun. 389, 295-300
36. Brynda, J., Rezacova, P., Fabry, M., Horejsi, M., Stouracova, R., Sedlacek, J., Soucek, M., Hradilek, M., Lepsik, M., and Konvalinka, J. (2004) A phenylnorstatine inhibitor binding to HIV-1 protease: a geometry, protonation, and subsite-pocket interactions analyzed at atomic resolution J. Med. Chem. 47, 2030-2036
37. Vedadi, M., Niesen, F. H., Allali-Hassani, A., Fedorov, O. Y., Finerty, P. J., Jr., Wasney, G. A., Yeung, R., Arrowsmith, C., Ball, L. J., Berglund, H., Hui, R., Marsden, B. D., Nordlund, P., Sundstrom, M., Weigelt, J., and Edwards, A. M. (2006) Chemical screening methods to identify ligands that promote protein stability, protein crystallization, and structure determination Proc. Natl. Acad. Sci. U.S. A. 103, 15835-15840
38. Niesen, F. H., Berglund, H., and Vedadi, M. (2007) The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability Nat. Protoc. 2, 2212-2221
39. Rücker, P., Horn, A., Meiselbach, H., and Sticht, H. (2011) A comparative study of HIV-1 and HTLV-I protease structure and dynamics reveals a conserved residue interaction network J. Mol. Model. 17, 2693-2705
40. Bornhop, D. J., Latham, J. C., Kussrow, A., Markov, D. A., Jones, R. D., and Sorensen, H. S. (2007) Free-solution, label-free molecular interactions studied by back-scattering interferometry Science 317, 1732-1736
41. Latham, J. C., Stein, R. A., Bornhop, D. J., and McHaourab, H. S. (2009) Free-solution label-free detection of alpha-Crystallin chaperone interactions by back-scattering interferometry Anal. Chem. 81, 1865-1871
42. Baksh, M. M., Kussrow, A. K., Mileni, M., Finn, M. G., and Bornhop, D. J. (2011) Label-free quantification of membrane-ligand interactions using backscattering interferometry Nat. Biotechnol. 29, 357-360
43. Kussrow, A., Baksh, M. M., Bornhop, D. J., and Finn, M. G. (2011) Universal sensing by transduction of antibody binding with backscattering interferometry ChemBioChem 12, 367-370
44. Kussrow, A., Enders, C. S., and Bornhop, D. J. (2011) Interferometric methods for label-free molecular interaction studies Anal. Chem. 84, 779-792
45. Olmsted, I. R., Xiao, Y., Cho, M., Csordas, A. T., Sheehan, J. H., Meiler, J., Soh, H. T., and Bornhop, D. J. (2011) Measurement of aptamer-protein interactions with back-scattering interferometry Anal. Chem. 83, 8867-8870
46. Buhler, B., Lin, Y. C., Morris, G., Olson, A. J., Wong, C. H., Richman, D. D., Elder, J. H., and Torbett, B. E. (2001) Viral evolution in response to the broad-based retroviral protease inhibitor TL-3 J. Virol. 75, 9502-9508
47. Irwin, J. J. and Shoichet, B. K. (2005) ZINC: a free database of commercially available compounds for virtual screening J. Chem. Inf. Model. 45, 177-182
48. Congreve, M., Carr, R., Murray, C., and Jhoti, H. (2003) A 'rule of three' for fragment-based lead discovery? Drug Discovery Today 8, 876-877